Lazard Asset Management LLC Grows Stake in Viemed Healthcare, Inc. $VMD

Lazard Asset Management LLC boosted its position in shares of Viemed Healthcare, Inc. (NASDAQ:VMD) by 117.6% in the first quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 215,938 shares of the company’s stock after acquiring an additional 116,700 shares during the quarter. Lazard Asset Management LLC’s holdings in Viemed Healthcare were worth $1,989,000 at the end of the most recent reporting period.

A number of other hedge funds also recently bought and sold shares of the company. North Star Investment Management Corp. purchased a new position in Viemed Healthcare in the first quarter worth about $921,000. Hillsdale Investment Management Inc. purchased a new stake in shares of Viemed Healthcare during the 1st quarter valued at about $1,834,000. Arrowstreet Capital Limited Partnership lifted its stake in shares of Viemed Healthcare by 101.9% in the 1st quarter. Arrowstreet Capital Limited Partnership now owns 711,186 shares of the company’s stock worth $6,550,000 after purchasing an additional 358,863 shares during the period. Expect Equity LLC lifted its stake in shares of Viemed Healthcare by 59.6% in the 4th quarter. Expect Equity LLC now owns 173,970 shares of the company’s stock worth $1,293,000 after purchasing an additional 64,961 shares during the period. Finally, BNP Paribas Financial Markets boosted its holdings in shares of Viemed Healthcare by 65.0% in the second quarter. BNP Paribas Financial Markets now owns 48,328 shares of the company’s stock worth $334,000 after buying an additional 19,047 shares during the last quarter. Hedge funds and other institutional investors own 74.24% of the company’s stock.

Viemed Healthcare Price Performance

NASDAQ VMD opened at $11.67 on Monday. The business’s fifty day moving average is $11.12 and its 200 day moving average is $9.66. Viemed Healthcare, Inc. has a fifty-two week low of $5.93 and a fifty-two week high of $12.61. The company has a debt-to-equity ratio of 0.06, a quick ratio of 1.10 and a current ratio of 1.22. The company has a market capitalization of $447.43 million, a PE ratio of 31.54 and a beta of 1.10.

Viemed Healthcare (NASDAQ:VMD) last issued its quarterly earnings results on Tuesday, May 5th. The company reported $0.06 EPS for the quarter, missing analysts’ consensus estimates of $0.09 by ($0.03). Viemed Healthcare had a return on equity of 10.52% and a net margin of 5.20%.The company had revenue of $75.41 million during the quarter, compared to analysts’ expectations of $74.40 million. Sell-side analysts predict that Viemed Healthcare, Inc. will post 0.44 earnings per share for the current year.

Analyst Ratings Changes

Separately, Weiss Ratings restated a “hold (c+)” rating on shares of Viemed Healthcare in a research report on Friday, July 17th. Two research analysts have rated the stock with a Hold rating, Based on data from MarketBeat, the company currently has a consensus rating of “Hold”.

Insider Buying and Selling

In other Viemed Healthcare news, insider William Frazier sold 10,000 shares of Viemed Healthcare stock in a transaction that occurred on Thursday, June 25th. The shares were sold at an average price of $11.72, for a total transaction of $117,200.00. Following the transaction, the insider owned 73,214 shares of the company’s stock, valued at $858,068.08. The trade was a 12.02% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Timothy Smokoff sold 20,000 shares of the company’s stock in a transaction that occurred on Wednesday, June 24th. The stock was sold at an average price of $11.50, for a total transaction of $230,000.00. Following the completion of the transaction, the director owned 75,518 shares of the company’s stock, valued at approximately $868,457. The trade was a 20.94% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. 20.60% of the stock is currently owned by company insiders.

About Viemed Healthcare

Viemed Healthcare, Inc (NASDAQ: VMD) is a provider of home-based respiratory therapy services, specializing in the management of patients requiring long-term mechanical ventilation and pulmonary support. The company’s offerings encompass invasive and noninvasive ventilation, airway clearance therapies, cough assist devices, and supplemental oxygen. Viemed combines durable medical equipment with clinical care, delivering tailored respiratory treatment plans that are overseen by licensed respiratory therapists and registered nurses.

Founded in the early 2010s and headquartered in Birmingham, Alabama, Viemed has grown its footprint to serve patients across multiple states in the United States.